She told reporters Friday that manufacturers are making unprecedented amounts of vaccine, but difficulties growing the vaccine, as well as time-consuming potency and purity testing, are contributing to the delay.

CNN: CDC: Production of H1N1 flu vaccine lagging

The only solution is testing for purity at every point in the supply chain, says Mr Harl.

ECONOMIST: Genetically modified crops